These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


344 related items for PubMed ID: 30102079

  • 1. Using antipsychotics for behavioral problems in children.
    Shafiq S, Pringsheim T.
    Expert Opin Pharmacother; 2018 Sep; 19(13):1475-1488. PubMed ID: 30102079
    [Abstract] [Full Text] [Related]

  • 2. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    Loy JH, Merry SN, Hetrick SE, Stasiak K.
    Cochrane Database Syst Rev; 2012 Sep 12; (9):CD008559. PubMed ID: 22972123
    [Abstract] [Full Text] [Related]

  • 3. Atypical Antipsychotics for Irritability in Pediatric Autism: A Systematic Review and Network Meta-Analysis.
    Fallah MS, Shaikh MR, Neupane B, Rusiecki D, Bennett TA, Beyene J.
    J Child Adolesc Psychopharmacol; 2019 Apr 12; 29(3):168-180. PubMed ID: 30707602
    [Abstract] [Full Text] [Related]

  • 4. Lurasidone for the treatment of irritability and anger in autism spectrum disorders.
    McClellan L, Dominick KC, Pedapati EV, Wink LK, Erickson CA.
    Expert Opin Investig Drugs; 2017 Aug 12; 26(8):985-989. PubMed ID: 28685626
    [Abstract] [Full Text] [Related]

  • 5. Dopamine antagonists for treatment resistance in autism spectrum disorders: review and focus on BDNF stimulators loxapine and amitriptyline.
    Hellings JA, Arnold LE, Han JC.
    Expert Opin Pharmacother; 2017 Apr 12; 18(6):581-588. PubMed ID: 28335658
    [Abstract] [Full Text] [Related]

  • 6. Psychopharmacological interventions in autism spectrum disorder.
    Accordino RE, Kidd C, Politte LC, Henry CA, McDougle CJ.
    Expert Opin Pharmacother; 2016 Apr 12; 17(7):937-52. PubMed ID: 26891879
    [Abstract] [Full Text] [Related]

  • 7. Aripiprazole for treating irritability associated with autism spectrum disorders.
    Bartram LA, Lozano J, Coury DL.
    Expert Opin Pharmacother; 2019 Aug 12; 20(12):1421-1427. PubMed ID: 31180743
    [Abstract] [Full Text] [Related]

  • 8. The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 2: antipsychotics and traditional mood stabilizers.
    Pringsheim T, Hirsch L, Gardner D, Gorman DA.
    Can J Psychiatry; 2015 Feb 12; 60(2):52-61. PubMed ID: 25886656
    [Abstract] [Full Text] [Related]

  • 9. A Focused Review on the Treatment of Pediatric Patients with Atypical Antipsychotics.
    Lee ES, Vidal C, Findling RL.
    J Child Adolesc Psychopharmacol; 2018 Nov 12; 28(9):582-605. PubMed ID: 30312108
    [Abstract] [Full Text] [Related]

  • 10. Pharmacologic Treatment of Severe Irritability and Problem Behaviors in Autism: A Systematic Review and Meta-analysis.
    Fung LK, Mahajan R, Nozzolillo A, Bernal P, Krasner A, Jo B, Coury D, Whitaker A, Veenstra-Vanderweele J, Hardan AY.
    Pediatrics; 2016 Feb 12; 137 Suppl 2():S124-35. PubMed ID: 26908468
    [Abstract] [Full Text] [Related]

  • 11. Use of Antipsychotics: The Experiences, Views, and Monitoring Practices of Child and Adolescent Psychiatrists in Turkey.
    Çakır B, Yalın Sapmaz Ş, Kandemir H.
    J Child Adolesc Psychopharmacol; 2021 Feb 12; 31(1):73-78. PubMed ID: 32614261
    [Abstract] [Full Text] [Related]

  • 12. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.
    Aman MG, Binder C, Turgay A.
    J Child Adolesc Psychopharmacol; 2004 Feb 12; 14(2):243-54. PubMed ID: 15319021
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological management of behavioral disturbances in children and adolescents with autism spectrum disorders.
    Lamy M, Erickson CA.
    Curr Probl Pediatr Adolesc Health Care; 2018 Oct 12; 48(10):250-264. PubMed ID: 30262163
    [Abstract] [Full Text] [Related]

  • 14. Risperidone in the management of disruptive behavior disorders.
    Pandina GJ, Aman MG, Findling RL.
    J Child Adolesc Psychopharmacol; 2006 Aug 12; 16(4):379-92. PubMed ID: 16958564
    [Abstract] [Full Text] [Related]

  • 15. Aripiprazole for autism spectrum disorders (ASD).
    Ching H, Pringsheim T.
    Cochrane Database Syst Rev; 2012 May 16; (5):CD009043. PubMed ID: 22592735
    [Abstract] [Full Text] [Related]

  • 16. Aripiprazole for the treatment of irritability and aggression in children and adolescents affected by autism spectrum disorders.
    Rizzo R, Pavone P.
    Expert Rev Neurother; 2016 Aug 16; 16(8):867-74. PubMed ID: 27388494
    [Abstract] [Full Text] [Related]

  • 17. Second-generation antipsychotics for the treatment of disruptive behaviour disorders in children: a systematic review.
    Pringsheim T, Gorman D.
    Can J Psychiatry; 2012 Dec 16; 57(12):722-7. PubMed ID: 23228230
    [Abstract] [Full Text] [Related]

  • 18. Atypical antipsychotic treatment of disruptive behavior disorders in children and adolescents.
    Findling RL.
    J Clin Psychiatry; 2008 Dec 16; 69 Suppl 4():9-14. PubMed ID: 18533763
    [Abstract] [Full Text] [Related]

  • 19. Head-to-Head Comparison of Aripiprazole and Risperidone in the Treatment of ADHD Symptoms in Children with Autistic Spectrum Disorder and ADHD: A Pilot, Open-Label, Randomized Controlled Study.
    Lamberti M, Siracusano R, Italiano D, Alosi N, Cucinotta F, Di Rosa G, Germanò E, Spina E, Gagliano A.
    Paediatr Drugs; 2016 Aug 16; 18(4):319-29. PubMed ID: 27278054
    [Abstract] [Full Text] [Related]

  • 20. Aripiprazole in the Treatment of Irritability in Children and Adolescents with Autism Spectrum Disorder in Japan: A Randomized, Double-blind, Placebo-controlled Study.
    Ichikawa H, Mikami K, Okada T, Yamashita Y, Ishizaki Y, Tomoda A, Ono H, Usuki C, Tadori Y.
    Child Psychiatry Hum Dev; 2017 Oct 16; 48(5):796-806. PubMed ID: 28004215
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.